CD4 and plasma cell myeloma: Flow cytometry showed an expansion of both CD8+ and CD4+ T cell populations and a significant increase in activated CD4+ and CD8+vβ (2, 3, 8.3)+ T cells, confirming their reactivity against myeloma target cells (Additional file 1: Figure S2).